NADPH Oxidase 1 Activity and ROS Generation Are Regulated by Grb2/Cbl-Mediated Proteasomal Degradation of NoxO1 in Colon Cancer Cells

Cancer Research
Jung Hee JooYun Soo Bae

Abstract

The generation of reactive oxygen species (ROS) is required for proper cell signaling, but must be tightly regulated to minimize deleterious oxidizing effects. Activation of the NADPH oxidases (Nox) triggers ROS production and, thus, regulatory mechanisms exist to properly control Nox activity. In this study, we report a novel mechanism in which Nox1 activity is regulated through the proteasomal degradation of Nox organizer 1 (NoxO1). We found that through the interaction between NoxO1 and growth receptor-bound protein 2 (Grb2), the Casitas B-lineage lymphoma (Cbl) E3 ligase was recruited, leading to decreased NoxO1 stability and a subsequent reduction in ROS generation upon epidermal growth factor (EGF) stimulation. Additionally, we show that EGF-mediated phosphorylation of NoxO1 induced its release from Grb2 and facilitated its association with Nox activator 1 (NoxA1) to stimulate ROS production. Consistently, overexpression of Grb2 resulted in decreased Nox1 activity, whereas knockdown of Grb2 led to increased Nox1 activity in response to EGF. CRISPR/Cas9-mediated NoxO1 knockout in human colon cancer cells abrogated anchorage-independent growth on soft agar and tumor-forming ability in athymic nude mice. Moreover, the expres...Continue Reading

References

Feb 1, 1994·Current Opinion in Genetics & Development·J Schlessinger
Jul 31, 1999·The Journal of Biological Chemistry·H WatermanY Yarden
Jan 5, 2002·Physiological Reviews·Wulf Dröge
Aug 15, 2002·Science's STKE : Signal Transduction Knowledge Environment·Anjaruwee Nimnual, Dafna Bar-Sagi
Mar 22, 2003·Current Opinion in Cell Biology·Ivan Dikic, Silvia Giordano
Dec 7, 2005·Biochemical and Biophysical Research Communications·Hye Sun ParkYun Soo Bae
Sep 19, 2006·The International Journal of Biochemistry & Cell Biology·Marian ValkoJoshua Telser
Feb 10, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John P Fruehauf, Frank L Meyskens
Jun 2, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Katrin SchröderRalf P Brandes
Dec 11, 2007·The FEBS Journal·Yi-Wei LouTzu-Ching Meng
Apr 25, 2008·Current Protocols in Immunology·W Strober
Jun 5, 2008·Antioxidants & Redox Signaling·Dunyaporn TrachoothamPeng Huang
Jan 20, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Moo Yeol LeeKathy K Griendling
Apr 11, 2009·Antioxidants & Redox Signaling·Gary M BokochDavide Gianni
May 15, 2009·Antioxidants & Redox Signaling·Thomas L LetoTakehiko Ueyama
May 30, 2009·Nature Reviews. Drug Discovery·Dunyaporn TrachoothamPeng Huang
Jun 6, 2009·Cancer Science·Tohru Kamata
Dec 17, 2009·Antioxidants & Redox Signaling·Andreas PetryAgnes Görlach
Mar 31, 2010·Nature Reviews. Clinical Oncology·Timothy J R Harris, Frank McCormick
Jan 26, 2011·Annals of the New York Academy of Sciences·Hung-Yun LinPaul J Davis
Dec 31, 2011·Molecules and Cells·Yun Soo BaeYoung Do Yoo
Aug 25, 2012·Nature Reviews. Cancer·Karen Block, Yves Gorin
Jan 17, 2013·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Maya DebbabiPham My-Chan Dang
Jan 31, 2013·Nature Biotechnology·Seung Woo ChoJin-Soo Kim
Jul 19, 2013·Nature Communications·Mads DaugaardPoul H Sorensen
Sep 21, 2013·Annual Review of Pathology·J David Lambeth, Andrew S Neish
Mar 19, 2014·Cell Death and Differentiation·M-T ParkS-J Lee
Jun 28, 2014·Nature Methods·Sangsu BaeJin-Soo Kim

❮ Previous
Next ❯

Citations

Nov 5, 2016·Free Radical Research·Hung-Chi YangDaniel Tsun-Yee Chiu
Jan 18, 2018·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Marie ErardOliver Nüße
Dec 26, 2019·Biomolecules & Therapeutics·Sae Rom LeeYun Soo Bae
Apr 5, 2016·Expert Opinion on Pharmacotherapy·Roberto Filippi, Filippo Montemurro
Jun 6, 2018·Frontiers in Immunology·Franziska MollKatrin Schröder
Sep 26, 2019·Frontiers in Pharmacology·Tao YangQun Wang
Dec 13, 2019·Antioxidants & Redox Signaling·Mathieu Chocry, Ludovic Leloup
Jul 23, 2020·Nature Metabolism·Michael SeimetzNorbert Weissmann
Sep 26, 2020·Cell Biochemistry and Function·Bhargav N WaghelaChandramani Pathak
Oct 22, 2020·Cell Reports·Jung-Yeon YooYun Soo Bae

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR in Cancer

CRISPR-Cas system enables the editing of genes to create or correct mutations. Given that genome instability and mutation is one of the hallmarks of cancer, the CRISPR-Cas system is being explored to genetically alter and eliminate cancer cells. Here is the latest research.